Celltrion
068270.KS
#779
Rank
โ‚ฌ27.00 B
Marketcap
123,44ย โ‚ฌ
Share price
-0.47%
Change (1 day)
4.63%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2025 (TTM): 1,65ย โ‚ฌ

According to Celltrion 's latest financial reports the company's current EPS (TTM) is 1,63ย โ‚ฌ. In 2023 the company made an earnings per share (EPS) of 2,38ย โ‚ฌ a decrease over its 2022 EPS that were of 2,43ย โ‚ฌ.

EPS history for Celltrion from 2007 to 2025

Annual EPS

Year EPS Change
2025 (TTM)1,65ย โ‚ฌ
20232,38ย โ‚ฌ-2.08%
20222,43ย โ‚ฌ-11.72%
20212,75ย โ‚ฌ2.03%
20202,70ย โ‚ฌ82.8%
20191,47ย โ‚ฌ18.31%
20181,25ย โ‚ฌ-36.33%
20171,96ย โ‚ฌ161.25%
20160,75ย โ‚ฌ2.86%
20150,73ย โ‚ฌ17.84%
20140,62ย โ‚ฌ5.87%
20130,58ย โ‚ฌ-70.85%
20122,00ย โ‚ฌ134.09%
20110,86ย โ‚ฌ43.59%
20100,60ย โ‚ฌ74.49%
20090,34ย โ‚ฌ317.8%
20080,08175ย โ‚ฌ-71.7%
20070,29ย โ‚ฌ